Board Member

Chris Mioton is a Partner at Shore Capital, a lower middle market private equity firm with approximately $12.5 billion of assets under management. 

Chris is responsible for sourcing, evaluating and enabling the growth of Shore healthcare investments. He is a Director for Innovate 32, Agentis Longevity, Southern Orthodontic Partners, SENTA, Assembly Health, OMS360, Triumph, Great Lakes Dental Partners, Empower Aesthetics and PartnerCare. He is a past Director of EyeSouth Partners.  

Chris received a B.A. in Economics from Northwestern University and an M.B.A. from the Kellogg School of Management at Northwestern University.